These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 33164355)

  • 1. [Investigation of active components and mechanism of Pudilan Xiaoyan Oral Liquid based on network pharmacology].
    Dang Y; Meng-Hua J; Chen-Zi LI; Wei-Quan BU; E S; Liang F; Xiao-Bin J
    Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4291-4298. PubMed ID: 33164355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of quality markers for Pudilan Xiaoyan Oral Liquid].
    Meng-Hua J; Chao LI; Fa-Gen Z; Wei-Quan BU; E S; Xiao-Bin J; Liang F
    Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4299-4306. PubMed ID: 33164356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Product improvement and secondary development of Pudilan Xiaoyan Oral Liquid based on clinical medication].
    Dang Y; Meng-Hua J; Hui-Min GU; E S; Liang F; Xiao-Bin J; Jun L; Jing Z; Chao LI
    Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4285-4290. PubMed ID: 33164354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimization and evaluation of Xiaoer Pudilan Xiaoyan Syrup based on characterization of material properties].
    Li X; Ding K; Yang D; Jiang MH; Li C; Zhu FG; Shao JG; Sun E; Feng L; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5746-5756. PubMed ID: 36471992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Source control of Pudilan Xiaoyan Oral Liquid--research on quality of Taraxaci Herba based on ultra high performance liquid chromatography fingerprint].
    Chao LI; Xiao-Nan SU; Fa-Gen Z; Fei WU; Wei-Quan BU; Liang F; Xiao-Bin J; Meng-Hua J; E S
    Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4307-4315. PubMed ID: 33164357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential absorption and metabolic characteristics of organic acid components in pudilan xiaoyan oral liquid between young rats and adult rats.
    Yang Y; Qian Z; Wu C; Cheng Y; Yang B; Shao J; Zhao J; Zhu X; Jia X; Feng L
    J Ethnopharmacol; 2024 Nov; 334():118528. PubMed ID: 38972526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Simultaneous determination of seven components in Pudilan Xiaoyan oral liquid by HPLC].
    Dong ZB; Li C; Shao JG
    Zhongguo Zhong Yao Za Zhi; 2015 May; 40(9):1747-50. PubMed ID: 26323141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of active ingredients of Pudilan Xiaoyan Oral Liquid in rats and effect on liver drug-metabolizing enzymes].
    Zhou YY; Gu XR; Li T; Bian BL; Wang HJ; Si N; Zhao HY
    Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4932-4939. PubMed ID: 31872603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meta-analysis on effectiveness and safety of Pudilan Xiaoyan Oral Liquid on child upper respiratory infection].
    Bai Y; Li YX; Shi YJ; Zhao HY
    Zhongguo Zhong Yao Za Zhi; 2020 May; 45(9):2203-2209. PubMed ID: 32495572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy evaluation and potential mechanism prediction on Pudilan Xiaoyan oral liquid in treatment of mumps in children based on meta-analysis, network pharmacology, and molecular docking.
    Liu Y; Cui X; Xi J; Xie Y
    Front Pharmacol; 2022; 13():956219. PubMed ID: 36210814
    [No Abstract]   [Full Text] [Related]  

  • 11. [Improvement of compliance of Pudilan Xiaoyan Oral Liquid based on comprehensive analysis of bad taste of traditional Chinese medicine oral liquid preparation].
    Dang Y; Meng-Hua J; Liang F; Jun L; Jing Z; E S; Xiao-Bin J
    Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4316-4323. PubMed ID: 33164358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systematic review of effectiveness and safety of pudilan Xiaoyan oral liquid in treating pediatric suppurative tonsilitis].
    Bian LL; Wang FW; Yang Y; Zhang L; Liu CX; Zhang JH; Zheng WK
    Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(8):1482-1488. PubMed ID: 29071850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GC-MS based metabolomic profiling of lung tissue couple with network pharmacology revealed the possible protection mechanism of Pudilan Xiaoyan Oral Liquid in LPS-induced lung injury of mice.
    Tian G; Li C; Zhai Y; Xu J; Feng L; Yao W; Bao B; Zhang L; Ding A
    Biomed Pharmacother; 2020 Apr; 124():109833. PubMed ID: 31958766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated metabolome-microbiome analysis investigates the different regulations of Pudilan Xiaoyan oral liquid in young rats with acute pharyngitis compared to adult rats.
    Ding K; Sun E; Huang R; Heng W; Li X; Liu J; Zhao J; Li C; Feng L; Jia X
    Phytomedicine; 2023 Nov; 120():155037. PubMed ID: 37611464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pudilan xiaoyan oral liquid alleviates LPS-induced respiratory injury through decreasing nitroxidative stress and blocking TLR4 activation along with NF-ΚB phosphorylation in mice.
    Feng L; Yang N; Li C; Tian G; Wang J; Dong ZB; Jia XB; Di LQ
    J Ethnopharmacol; 2018 Mar; 214():292-300. PubMed ID: 28689797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effective delivery of quality markers in alcohol precipitation of Pudilan Xiaoyan Oral Liquid].
    Huang R; Jiang MH; Sun E; Li C; Zhu FG; Shao JG; Feng L; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5757-5764. PubMed ID: 36471993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reference substance free diagnostic fragment ion-based approach for rapid identification of non-target components in Pudilan Xiaoyan oral liquid by high resolution mass spectrometry.
    Dai C; Wang C; Zhang C; Wang G; Wang J; Chen J; Guo B; Yang T; Cai B
    J Pharm Biomed Anal; 2016 May; 124():79-92. PubMed ID: 26938159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification and attribution of chemical compounds of Pudilan Antiphlogistic Oral Liquid].
    Zhao LJ; Gao WY; Gu XR; Wang HJ; Zhao HY; Bian BL
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1573-1587. PubMed ID: 31090321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated metabolism, network pharmacology, and pharmacokinetics to explore the exposure differences of the pharmacodynamic material basis in vivo caused by different extraction methods for Saussurea involucrata.
    Yang L; Lyu H; Yiming A; Xu X; Ma C; Tu S; Chen B; Liu M; Wu C
    J Ethnopharmacol; 2022 Nov; 298():115648. PubMed ID: 35987408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expert consensus statement on Pudilan Xiaoyan Oral Liquid in clinical practice].
    Wang LX; Miao Q; Xie YM; Chen DC; Sun SL; Zhang HC; Jia ZW; Li TN; Zhu J; Shi LQ; Song P; Gao F; Wei BL; Feng CL; Qu YQ; Qu NN; Yu XF; Zhang NZ; Yu XQ
    Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5277-5281. PubMed ID: 32237368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.